Breaking NGS Ground
CMS Final Coverage Determination Promotes Sequencing-Based Testing for Advanced Cancer
Top 10 Under 40
Biopharma Research and Businesses Benefit from Contributions of Emerging Leaders
Genomics Gets Personal
Despite Data and Privacy Challenges, Decreasing Cost Ushers in the Age of Personalized Whole-Genome Sequencing
The Scoop: St. Jude to Build a Collab-Fostering Research Hub
Ground Will Be Broken for a 625,000-Square-Foot Facility to Be Completed in 2021
For full access to this article login to GEN Select now.
Roslin Cells & Lonza Take On Stem Cell Media
Ultimate Goal of Initiatives Is to Facilitate Translation of Innovation into Regenerative Therapies
- Earlier this year Roslin Cells and Lonza signed a stem cell media development deal the firms hope will play a key role in the drive to translate scientific innovation in the stem cells field into clinically applied regenerative therapies. The agreement is centered on the development of clinical-grade ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.